In Florida, Which Activities Are Only Permitted by Law?

The Florida Drug and Cosmetic Act, codified as Chapter 499 of the Florida Statutes, governs how drugs, devices, and cosmetics are manufactured, stored, and distributed inside the state. It is administered by the Department of Business and Professional Regulation (DBPR), which issues permits, inspects facilities, and enforces the rules with administrative fines up to $5,000 per day and criminal penalties that run as high as life imprisonment for the worst offenses.¹ If your business touches any of these products in Florida, the act almost certainly applies to you.

Who Needs a Permit

Almost any business that manufactures, repackages, wholesales, or distributes drugs, devices, or cosmetics in Florida must hold a DBPR permit. The act creates separate permit categories for each activity, including prescription drug manufacturer, prescription drug repackager, prescription drug wholesale distributor, retail pharmacy drug wholesale distributor, out-of-state prescription drug wholesale distributor, restricted drug distributor, and special sterile compounding permits.²

A permit can only be issued to an individual who is at least 18, or to a business entity where every person who manages or oversees operations is at least 18. Home-based operations are flatly prohibited; no permit will be issued to a residential address. Prescription drug wholesale distributor applicants must also post a surety bond of $100,000, or $25,000 if annual gross receipts are $10 million or less.²

A county or municipality cannot issue an occupational license to any establishment that requires a Chapter 499 permit unless the business already holds a current DBPR permit.²

What the Act Prohibits

Chapter 499 spells out a broad list of unlawful activities. The core prohibition is selling or holding for sale any drug, device, or cosmetic that is adulterated or misbranded. Adulteration covers products that are contaminated, improperly manufactured, or stored under conditions that compromise their integrity. Misbranding covers false or misleading labeling, including efficacy claims that are not true.³

The act also prohibits:

Disseminating false or misleading advertisements for a drug, device, or cosmetic.
Creating counterfeit drugs, devices, or cosmetics, or knowingly selling counterfeit products.
Altering, destroying, or removing any part of a product’s labeling while it is held for sale.
Buying or selling prescription drugs for wholesale distribution in exchange for cash currency.
Refusing to let DBPR agents enter or inspect an establishment, its records, or its transport vehicles, or refusing to allow sampling.
Selling HIV self-testing kits unless the kit has been approved by the FDA for home use.

These prohibitions apply to anyone who performs the act or causes someone else to perform it. An owner who directs an employee to mislabel a product is personally liable, not just the employee doing the labeling.³

Storage and Handling Rules

Any establishment that warehouses, handles, or displays prescription drugs has to meet detailed facility standards. Facilities must be properly sized and designed to provide adequate lighting, ventilation, temperature control, humidity management, and security. Each facility needs a separate quarantine area for drugs that are outdated, damaged, misbranded, or in opened containers.⁴

All prescription drugs must be stored at temperatures and conditions that match their labeling or official compendium standards. When a drug has no specific storage requirement, it can be held at controlled room temperature as defined by the official compendium. Facilities must record temperature and humidity using manual or electronic equipment. Inventories must be examined at least every 12 months, and expired products must be pulled and quarantined.⁴

Returned drugs get special treatment. If there is any doubt about a returned product’s safety, identity, strength, quality, or purity, the drug must be destroyed or sent back to the supplier unless testing confirms it still meets standards. Returned product cannot go back on the shelf without a documented evaluation.

Inspections and Recordkeeping

DBPR agents and agents of the Department of Law Enforcement may inspect any permitted establishment during business hours after presenting proper identification. The authority extends to monitoring compliance with Chapters 499, 465, 501, and 893 and with any departmental rules that protect public health.⁵

Inspectors can collect samples of any drug, device, or cosmetic and gather evidence for enforcement. The department can also administer oaths, take depositions, issue subpoenas, and compel production of records during investigations.⁵ Persons who are exempt from permitting but still distribute prescription drugs within or into Florida have to make their records available to DBPR within 48 hours of a request.⁶

Administrative Penalties

DBPR can impose an administrative fine of up to $5,000 per violation per day. Each day a violation continues counts as a separate violation, so costs accumulate fast when problems are not corrected. The department can also suspend or revoke permits, and in emergencies it can issue an immediate suspension if conditions at a facility present a danger to public health.⁷

Enforcement is tiered. Less serious issues can draw a notice of violation, warning letter, or notice of inspection results. More serious violations trigger an administrative complaint with fines in the $3,000 to $5,000 range per violation and possible permanent suspension or revocation.⁸ Resigning from a business or terminating an affiliated party does not stop DBPR from proceeding.⁷

Criminal Penalties

Criminal consequences escalate with the severity of the conduct and whether anyone was harmed.

Device and cosmetic offenses sit at the lower end. Selling an adulterated cosmetic or running a false advertisement for a medical device is generally a second-degree misdemeanor, rising to a first-degree misdemeanor on a repeat offense. Counterfeiting a device or cosmetic, however, is a third-degree felony carrying up to five years in prison.⁹¹⁰

Drug offenses carry stiffer penalties. Selling adulterated or misbranded drugs, running false drug advertisements, or failing to maintain required records is a second-degree misdemeanor for a first offense and a first-degree misdemeanor for repeat offenders. The harshest penalties are reserved for counterfeiting and trafficking:

Creating, selling, or knowingly holding a counterfeit drug is a second-degree felony, punishable by up to 15 years in prison.⁹¹⁰
Knowingly forging or falsely creating a prescription label or prescription drug label is a first-degree felony.⁹
Selling or possessing contraband prescription drugs where someone suffers great bodily harm is a first-degree felony.⁹
If someone dies as a result, the offense is a first-degree felony punishable by up to life in prison.⁹

Federal charges can stack on top. Under federal law, knowingly trafficking in counterfeit prescription drugs carries up to 10 years in prison and fines up to $250,000. Violations committed with intent to defraud carry up to three years and $10,000 in fines, even without a counterfeiting element.¹¹

Who Is Exempt

Drugs compounded by a pharmacist licensed under Chapter 465 in a pharmacy operating under a Board of Pharmacy permit are exempt from the adulteration provisions of Section 499.025. Qualified persons engaged in lawful research, teaching, or testing can possess prescription drugs without holding a standard distribution permit, though DBPR may adopt rules governing these activities and issue letters of exemption.¹² The act also recognizes exempt cosmetic manufacturers.

Exemption is narrow. It means you don’t need the specific permit; it does not mean DBPR has no authority over you. The department can still investigate complaints against an exempt cosmetic manufacturer and send inspectors to the premises, and refusing to allow an inspection remains a prohibited act under Section 499.005(6).⁶ The prohibited-acts provisions and criminal penalties apply to exempt persons as well.

Federal Rules That Also Apply

Chapter 499 is not the whole picture. Florida cosmetic manufacturers also have to comply with the federal Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which requires manufacturers and processors to register their facilities with the FDA and renew every two years. A “responsible person,” the manufacturer, packer, or distributor named on the label, must list each marketed product with the FDA and update annually. Serious adverse events have to be reported to the FDA within 15 business days.¹³¹⁴

Prescription drug distributors must also comply with the federal Drug Supply Chain Security Act (DSCSA), which requires electronic, interoperable, package-level tracing of prescription drugs across the supply chain. If any party determines a product is illegitimate, the DSCSA requires notification to the FDA and all immediate trading partners within 24 hours.¹⁵

A separate layer applies to businesses in the imported drug supply chain. The FDA has authorized Florida’s Agency for Health Care Administration to operate a drug importation program under Section 804 of the Federal Food, Drug, and Cosmetic Act, with obligations that include maintaining supply chain integrity, submitting adverse event reports, following recall procedures, and reporting quarterly to the FDA.¹⁶

1
The Florida Senate. Florida Statutes 499.003 – Definitions
2
The Florida Senate. Florida Statutes 499.012 – Permit Requirements
3
Florida Senate. Florida Statutes 499.005 – Prohibited Acts
4
The Florida Senate. Florida Statutes 499.0121 – Storage and Handling
5
Florida Senate. Florida Statutes 499.051 – Inspections and Investigations
6
The Florida Senate. Florida Statutes 499.01 – Department Powers and Duties
7
The Florida Senate. Florida Statutes 499.066 – Administrative Penalties
8
Legal Information Institute. Florida Administrative Code R. 61N-1.024 – Administrative Enforcement
9
Florida Senate. Florida Statutes 499.0051 – Criminal Acts
10
The Florida Senate. Florida Statutes 775.082 – Penalties
11
Office of the Law Revision Counsel. 21 U.S. Code 333 – Penalties
12
Florida Senate. Florida Statutes Chapter 499 – Florida Drug and Cosmetic Act
13
U.S. Food and Drug Administration. Registration and Listing of Cosmetic Product Facilities and Products
14
U.S. Food and Drug Administration. Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
15
U.S. Food and Drug Administration. Notify FDA of Illegitimate Products
16
Food and Drug Administration. FDA Authorizes Florida’s Drug Importation Program